CREB3L1 and brain glioma: In contrast with the CREB3L1-positive patients, a decrease in survival proportion (%) for the CREB3L1-negative patients was more obvious with an initial decrement observed at the time point of the seventh month after the brain glioma was surgically excised (Figure 4A).